OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Kentucky (P)

6 Projects | 5 Researchers | $2,268,073 Invested

2018

University of Kentucky (P)

Linda Van Eldik, PhD

Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease

  • Funding Amount: $1,434,160
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Closed

2016

University of Kentucky (P)

Christopher Norris, PhD

Preclinical assessment of the therapeutic utility of small molecule inhibitors of the calcineurin/NFAT system in Alzheimer's disease

  • Funding Amount: $257,552
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed

2014

University of Kentucky (P)

Peter Nelson, MD, PhD

Testing a novel therapeutic strategy for hippocampal sclerosis of aging, a common AD mimic

  • Funding Amount: $149,997
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2014

University of Kentucky (P)

Linda Van Eldik, PhD

Bridge Funding for Reissue of IND for Phase 1b/2a

  • Funding Amount: $209,364
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Closed

2012

University of Kentucky (P)

Steven Estus, PhD

Translating genetics into biomarkers and therapies: apoE/Ab and apoJ/Ab complex levels and lipidation state as AD biomarkers modulated by VPA

  • Funding Amount: $117,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2007

University of Kentucky (P)

Louis Hersh, PhD

Neprilysin and Peripheral Clearance of Amyloid Peptides

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed